H
Henrik Larsson
Researcher at Karolinska Institutet
Publications - 743
Citations - 35001
Henrik Larsson is an academic researcher from Karolinska Institutet. The author has contributed to research in topics: Population & Medicine. The author has an hindex of 81, co-authored 616 publications receiving 27275 citations. Previous affiliations of Henrik Larsson include University of Gothenburg & King's College London.
Papers
More filters
Journal ArticleDOI
Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols.
Paul S. Tofts,Gunnar Brix,David L. Buckley,Jeffrey L. Evelhoch,Elizabeth Henderson,Michael V. Knopp,Henrik Larsson,Ting-Yim Lee,Nina A. Mayr,Geoffrey J. M. Parker,Ruediger E. Port,June S. Taylor,Robert M. Weisskoff +12 more
TL;DR: A standard set of quantity names and symbols related to the estimation of kinetic parameters from dynamic contrast‐enhanced T1‐weighted magnetic resonance imaging data, using diffusable agents such as gadopentetate dimeglumine (Gd‐DTPA), are described.
Journal ArticleDOI
The familial risk of autism.
Sven Sandin,Paul Lichtenstein,Ralf Kuja-Halkola,Henrik Larsson,Christina M. Hultman,Abraham Reichenberg +5 more
TL;DR: Among children born in Sweden, the individual risk of ASD and autistic disorder increased with increasing genetic relatedness and support for a disease etiology including only additive genetic and nonshared environmental effects was found.
Journal ArticleDOI
Genetics of attention deficit hyperactivity disorder
TL;DR: From studies of copy number variants, it is learned that the rare insertions or deletions account for part of ADHD’s heritability, which has implicated new biological pathways that may eventually have implications for treatment development.
Journal ArticleDOI
Premature mortality in autism spectrum disorder.
Tatja Hirvikoski,Ellenor Mittendorfer-Rutz,Marcus Boman,Henrik Larsson,Paul Lichtenstein,Sven Bölte +5 more
TL;DR: Premature mortality was markedly increased in ASD owing to a multitude of medical conditions and Mortality and patterns for cause-specific mortality were partly moderated by gender and general intellectual ability.
Journal ArticleDOI
Medication for Attention Deficit–Hyperactivity Disorder and Criminality
Paul Lichtenstein,Linda Halldner,Johan Zetterqvist,Arvid Sjölander,Eva Serlachius,Seena Fazel,Niklas Långström,Henrik Larsson +7 more
TL;DR: It is raised the possibility that the use of medication reduces the risk of criminality among patients with ADHD, and rates of criminality were lower during periods when they were receiving ADHD medication.